leadf
logo-loader
viewTissue Regenix Group PLC

Tissue Regenix develops product extension to be used in female pelvic medicine

Interim chief executive Gareth Jones said: “Our commercial success is predicated on our ability to identify new clinical applications and rapidly develop product lines to meet this demand."

Tissue Regenix Group PLC -

Tissue Regenix Group PLC (LON:TRX) has unveiled a product extension based on DermaPure, the company’s technology for skin repair, or reinforcement.

DermaPure Non-Oriented has two identical sides, meaning the orientation of the graft is not a factor during implantation, making it easier to apply.

It will be used in uro-gynecological (female pelvic medicine) and will be sold by partner and specialist distributor, ARMS Medical. 

Interim chief executive Gareth Jones said: “Our commercial success is predicated on our ability to identify new clinical applications and rapidly develop product lines to meet this demand.

“Working closely with our strategic partner, ARMS Medical, we are confident that DermaPure Non-Oriented will offer our clinicians the clinical outcomes and health economic benefits they require.

“We continue to see the growing demand for DermaPure, as demonstrated in our recent interim results, and expect that DermaPure Non–Oriented will augment this product portfolio, driving adoption by physicians in the future.”

Quick facts: Tissue Regenix Group PLC

Price: 0.3397 GBX

AIM:TRX
Market: AIM
Market Cap: £23.89 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Morning Report: FTSE 100 heads higher as markets welcome easing of restrictions

Headlines from the Proactive UK newsroom. The FTSE 100 rose 21 points to 6,957 as markets welcomed more easing of coronavirus lockdown measures across Europe despite some confusion in the UK. UK prime minister Boris Johnson, though, is being pressed for more clarity on the relaxation of UK...

on 11/5/20

2 min read